Previous Close | 9.88 |
Open | 9.91 |
Bid | 9.73 x 300 |
Ask | 9.78 x 1000 |
Day's Range | 9.64 - 10.19 |
52 Week Range | 4.89 - 22.69 |
Volume | |
Avg. Volume | 3,878,263 |
Market Cap | 564.046M |
Beta (5Y Monthly) | 2.17 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.91 |
Earnings Date | Apr 01, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 18.30 |
Subscribe to Yahoo Finance Plus to view Fair Value for NNOX
With share prices ascending everywhere, this young business has enjoyed a lift.
PETAH TIKVA, Israel, March 18, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter and fiscal year ended December 31, 2023, before market open on Monday, April 1, 2024. Erez Meltzer, Chief Executive Officer, and Ran Daniel, Chief Financial Officer, will host a conference call to review these results and provide a business update beginning
– According to early findings in the ADOPT study, Nanox.AI software improves detection of key risk factor for osteoporosis, outperforming UK National Health Service national average – Findings demonstrate real-world impact of integrating AI technology in routine chest and abdomen CT scans to improve detection of spine fracture, an early sign of osteoporosis PETACH TIKVA, Israel, March 12, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company," Nasdaq: NNOX), an innovative medical